AZZ Inc. (AZZ) said Monday that its President and Chief Executive Officer, David Dingus, has been recently diagnosed with cancer of the pancreas.
Dingus will begin an aggressive treatment commencing the week of March 4.
It is anticipated that during this period of treatment, all day-to-day operations will continue to be conducted by the organization currently in place, the company said and added that Dingus will continue in his role of Chief Executive Officer.
AZZ said Dingus and the senior management team will continue to work with the Board of Directors to continue to seek out all opportunities for profit enhancement, growth and expansion of the existing businesses and the successful implementation of the Aquilex SRO acquisition should the company receive the anticipated government approval to proceed.
Dingus may have a reduced work schedule during certain periods of his treatment, but he is not expected to be away for any extended periods of time, the company noted.
by RTT Staff Writer
For comments and feedback: firstname.lastname@example.org